Gilead's twice-yearly HIV prevention injection gets FDA approval
The US Food and Drug Administration has approved Gilead's (GILD) new HIV prevention drug. The drug, lenacapavir, only requires an injection every 6 months. Yahoo Finance Healthcare Reporter Anjalee Khemlani reports the details.
To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.
What's a big milestone for Gilead Sciences today. The Biotech Giant securing FDA approval for its latest HIV treatment. It's a significant step forward for that company and patients. Gilead also seeing a boost on that news. Our senior health reporter Anjali kamlani joins us now. Au, what is what is the big takeaway for for investors watching all this?
Yeah, I think the big takeaway here is that investors have actually been waiting for this approval. They anticipate quick uptake and a high volume of uptake of this drug used as a pre-exposure prophylaxis, you know, prep as the common acronym for those types of drugs. Now, Gilead already has discovy for that, but the difference here is that this new use or new approval for Lenca Paviar, it is a twice yearly injectable. And that is the difference between the regular oral and this new approval. And so that is really going to help boost Gilead's revenues for the year. We know that already Lenca Paviar brings in about $60 million for the company, and they're anticipating that that will get boosted to about $150 to $195 million in revenue for the company for the year. That's the estimate that analysts are expecting with the approval, and they've been waiting for this approval for quite some time. So really good news. You can see that, you know, the stock is benefiting from this right now and is supposed to be a game changer for those patients. There are some questions about whether or not being a twice yearly drug, it will be more expensive than say a daily oral. And so that is something that Gilead has tried to addressing that they plan to have a insurance and non-insurance access point for patients as well.
Thanks so much for joining us on this. Appreciate it.
Error while retrieving data
Sign in to access your portfolio
Error while retrieving data
Error while retrieving data
Error while retrieving data
Error while retrieving data
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Fabletics Elevates Key Leaders as It Eyes $1 Billion Milestone
Fabletics has announced two key executive leadership Bhatia, who previously served as chief operating officer, has been elevated to president and COO. She has driven initiatives across e-commerce, production, operations and technology, while leading the brand's expansion into new channels. Her role now spans product creation, retail, wholesale and international Gomez, formerly senior vice president of brand marketing, is now chief marketing officer. She will lead all brand, digital innovation and customer engagement initiatives. According to Fabletics, Gomez has been leveraging customer insights to inform impactful marketing in 2013 and headquartered in El Segundo, Calif., the activewear brand operates on a membership-based model rooted in e-commerce and supported by a growing number of retail stores. Owned by TechStyle Fashion Group, Fabletics is on track to exceed $1 billion in revenue, according to Adam Goldenberg, Fabletics' cofounder and chief executive officer. He, Bhatia and Gomez have worked closely to guide the company's growth.'We're introducing new store formats and pursuing plans for international expansion — all while continuing to deliver the innovative partnerships and best-in-class product we are known for,' said Goldenberg in a statement. 'We are thrilled to have Meera and Carly expand their roles and position us for continued success.''I am honored to assume the roles of president and COO at Fabletics during a time of immense growth and international expansion,' said Bhatia. 'Fabletics is a driving force in an evolving activewear industry, leading from design, product, technology and community. I look forward to helping lead the brand to new heights in my new role.''I joined Fabletics last year because I believe it is at the cutting edge of customer engagement, and is truly reinventing the activewear space,' said Gomez. 'Stepping into the CMO role, I am excited to unlock new ways of elevating our brand and delivering an impactful customer experience that propels Fabletics forward in this next chapter.' More from WWD David Beckham Launches Beeup, Honey Fruit Gummies, With Shaun Neff Tracy Anderson Introduces New Studio Concept in Santa Monica: Privé Kathy Gohari Named President of Rodeo Drive Committee Best of WWD Kate Middleton's Looks at Trooping the Colour Through the Years [PHOTOS] Young Brooke Shields' Style Evolution, Archive Photos: From Runway Modeling & Red Carpets to Meeting Princess Diana The Most Memorable French Open Tennis Outfits With Serena Williams, Naomi Osaka & More [PHOTOS]
Wall Street Journal
25 minutes ago
- Wall Street Journal
Salesforce Not Taking Survival for Granted in AI Era, Top Strategist Says
Salesforce CRM -1.08%decrease; red down pointing triangle is a giant in its field, but Peter Schwartz, one of its top strategists, isn't taking survival for granted in the era of artificial intelligence. The unprecedented pace of change brought by AI is forcing the software maker to reinvent itself, or risk being put out of business, said Schwartz, chief futures officer of Salesforce.
Bloomberg
26 minutes ago
- Bloomberg
Political Woes Threaten to Sink Thai Economy Deeper Into Malaise
Thailand's sudden descent into a new political crisis threatens an economy that's already on the brink of a technical recession and bracing for the impact of the global trade war. Even if Thai Prime Minister Paetongtarn Shinawatra manages to survive a widening rift in the ruling coalition, analysts said the fallout could stall key legislation, undermine US tariff talks and shake investor confidence in already-underperforming Thai assets.
